Sennosides And Docusate Sodium Tablet
FDA Label NDC 55154-2578

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Sennosides And Docusate Sodium (NDC 55154-2578). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, ask a doctor before use if you, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient (In Each Tablet)

Docusate Sodium         50 mg
Sennosides            8.6 mg

Purpose

Stool softener
Laxative

Ask A Doctor Before Use If You

  • have abdominal pain, nausea or vomiting
  • are taking mineral oil
  • have noticed a sudden change in bowel habits that lasts over two weeks

Stop Use And Ask A Doctor If

you have rectal bleeding or fail to have a bowel movement after use of a laxative.
These may indicate a serious condition.

If Pregnant Or Breast-Feeding,

ask a health professional before use.

Keep Out Of Reach Of Children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Packaging Information

Distributed by:
American Health Packaging, Columbus, Ohio 43217

762201

Distributed By:

Cardinal Health

Dublin, OH 43017

L58458880723


0462201/0621A

Principal Display Panel

Sennosides and Docusate Sodium Tablets

Natural Vegetable Laxative with Stool Softener

8.6 mg/ 50 mg

10 Tablets

Bag Label (Image 01)

Bag Label (Image 01)

* Please review the disclaimer below.